Medicare Enrolled

Dr. Vincent Labruna, DPM

Podiatrist · Oakland, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
43 YAWPO AVE, Oakland, NJ 07436
2013375150
In practice since 2006 (20 years)
NPI: 1578518114 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Labruna from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Labruna? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Labruna

Dr. Vincent Labruna is a podiatrist in Oakland, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Labruna performed 2,331 Medicare services across 935 unique beneficiaries.

Between the years covered by Open Payments, Dr. Labruna received a total of $3,084 from 20 pharmaceutical and/or device companies across 31 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in podiatrist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Labruna is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 29% volume in NJ $3,084 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,331
Medicare services
Top 29% in NJ for podiatrist
935
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~117 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Toenail/fingernail removal, 1-5 nails
This procedure involves the removal of one to five fingernails or toenails.
709 $28 $38
Trimming of dystrophic nails
Trimming of dystrophic nails, any number
586 $13 $28
Removal of noncancer thickened skin growth, 1 growth
This procedure involves the removal of a single benign, thickened skin growth. It is a minor surgical intervention to eliminate the lesion.
365 $63 $88
Removal of thickened skin growths, 2-4
This procedure involves the removal of two to four benign, thickened skin growths. It is a minor surgical intervention to eliminate non-cancerous skin lesions.
231 $74 $100
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
147 $47 $65
Toenail/fingernail removal, 6+ nails
Surgical removal of six or more fingernails or toenails. This procedure involves the excision of multiple nails during a single session.
126 $36 $51
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
54 $58 $84
Simple drainage of skin abscess
A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing.
38 $112 $146
Ankle or foot strapping
Application of supportive bandages or tape to the ankle or foot to provide stability and protection.
29 $23 $40
Wound tissue removal, 20 sq cm or less
This procedure involves the removal of tissue from a wound area measuring 20 square centimeters or less.
20 $87 $121
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
14 $73 $94
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
12 $89 $124
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,084
Total received (2018-2024)
Avg $441/year across 7 years
Top 21% in NJ for podiatrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
20
Companies
31
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,084 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$692
2023
$380
2022
$752
2021
$310
2020
$136
2019
$394
2018
$421

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
TREACE MEDICAL CONCEPTS, INC.
$150
Next Science LLC
$142
Amgen Inc.
$142
Smith+Nephew, Inc.
$139
Integra LifeSciences Corporation
$118
Top 3 companies account for 62.8% of 2024 payments
All-time payments by company (2018-2024) ›
Smith+Nephew, Inc.
$458
TREACE MEDICAL CONCEPTS, INC.
$277
Zimmer Biomet Holdings, Inc.
$258
Abbott Laboratories
$217
Ortho Dermatologics, a division of Bausch Health US, LLC
$204
Organogenesis Inc.
$202
Amgen Inc.
$157
Next Science LLC
$142
Royal Biologics, Inc.
$122
Paragon 28, Inc.
$122
ABBVIE INC.
$122
ORGANOGENESIS INC.
$122
GRT US Holding, Inc.
$121
Paratek Pharmaceuticals, Inc.
$120
Integra LifeSciences Corporation
$118
Osiris Therapeutics Inc.
$99
KCI USA, Inc
$98
Cardiovascular Systems Inc.
$80
Alfasigma USA, Inc.
$26
Boston Scientific Corporation
$19
Top 3 companies account for 32.2% of all-time payments
Associated products mentioned in payments ›
ACTIVAC · Aimovig · Apligraf · CERAMENTBONE VOID FILLER · DALVANCE · Diamondback Peripheral · Fibrinet · GRAFIX PL · GRAFIX/GRAFIXPL/STRAVIX · Grafix PRIME · Integra · JUBLIA · KRYSTEXXA · LAPIPLASTY SYSTEM · MTP FUSION PLATES · NUZYRA · PROCLAIM · Puraply · Qutenza · REGRANEX · SlimTip lead DRG Lead · Stravix · Subchondroplasty · WATCHMAN Access System · Xperience
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a podiatrist in Oakland?
Compare podiatrists in the Oakland area by procedure volume, costs, and industry payment transparency.
Browse podiatrists nearby

Geographic Context

Podiatrists within 10 mi
500
Per 100K population
52.4
County median income
$123,715
Nearest hospital
RAMAPO RIDGE BEHAVIORAL HEALTH HOSPITAL
4.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Labruna is a mixed practice specialist, with above-average Medicare volume (top 29% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Labruna experienced with toenail/fingernail removal, 1-5 nails?
Based on Medicare claims data, Dr. Labruna performed 709 toenail/fingernail removal, 1-5 nails services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Labruna receive payments from pharmaceutical companies?
Yes. Dr. Labruna received a total of $3,084 from 20 companies across 31 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Labruna's costs compare to other podiatrists in Oakland?
Dr. Labruna's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Labruna) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →